Korenberg Matthew E
SEC insider (Form 3/4/5 filer). CIK 0001649903. CFO, Treasurer at PALVELLA THERAPEUTICS, INC. (PVLA) and 2 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in CHASKA, MN.
Companies Korenberg Matthew E has filed insider reports for
- PALVELLA THERAPEUTICS, INC. (PVLA): Officer, CFO, Treasurer
- LIFECORE BIOMEDICAL, INC. \DE\ (LFCR): Director
- LIGAND PHARMACEUTICALS INC (LGND): Officer, President & COO
Korenberg Matthew E
CIK: 0001649903
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jun 12, 2026PVLA
PALVELLA THERAPEUTICS, INC.
ExerciseDirect1K shares at avg. $13.60$14K - Jun 4, 2026LFCR
LIFECORE BIOMEDICAL, INC. \DE\
AwardDirect25.9K shares- - Feb 5, 2026PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
44.1K shares- - Jul 15, 2025LFCR
LIFECORE BIOMEDICAL, INC. \DE\
AwardDirect19.5K shares- - Feb 5, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectIncentive Stock Option (right to buy)
5.4K shares- - Feb 5, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectNon-Qualified Stock Option (right to buy)
123.6K shares- - Dec 13, 2024PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
167.1K shares- - Sep 23, 2024LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect9.4K shares at avg. $52.84$495K - Sep 23, 2024LGND
LIGAND PHARMACEUTICALS INC
ExerciseDirect395 shares at avg. $49.99$20K - Sep 23, 2024LGND
LIGAND PHARMACEUTICALS INC
SaleDirect201 shares at avg. $102.05$21K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  PVLA PALVELLA THERAPEUTICS, INC. | Exercise | 1,000 | $13.60 | $13,600 | Direct |
| Jun 4, 2026 |  LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Award | 25,907 | - | $0 | Direct |
| Feb 5, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 44,123 | - | - | Direct |
| Jul 15, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | Award | 19,506 | - | - | Direct |
| Feb 5, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Incentive Stock Option (right to buy) | 5,373 | - | - | Direct |
| Feb 5, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Non-Qualified Stock Option (right to buy) | 123,559 | - | - | Direct |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (right to buy) | 167,100 | - | - | Direct |
| Sep 23, 2024 |  LGND LIGAND PHARMACEUTICALS INC | Exercise | 9,377 | $52.84 | $495,481 | Direct |
| Sep 23, 2024 | LGND LIGAND PHARMACEUTICALS INC | Exercise | 395 | $49.99 | $19,746 | Direct |
| Sep 23, 2024 | LGND LIGAND PHARMACEUTICALS INC | Sale | 201 | $102.05 | $20,513 | Direct |
1-10 of 22 transactions